Clinical trial
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or…
NCT00003950 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00003950 |
|---|---|
| Title | Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer |
| Official title | A Phase II Trial of Irinotecan (CPT-11) and Cyclosporine in Patients With 5-FU Refractory Advanced Colorectal Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | cyclosporine, CPT-11 |
| Enrollment | 16 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2001 |
| Completion | Jan 1, 2005 |
| First posted | Apr 27, 2004 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: